About the journal
Biomarkers in Neuropsychiatry is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,140 USD. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2666-1446
- Country
- Netherlands
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,140 USD
- Articles in DOAJ
- 124
- Declared review time
- 20 weeks
- Declared peer-review model
- other
Index listings
- DOAJ · 2020-05-18
- Indexing
- DOAJ
- APC
- 3,140 USD
- Declared review time (DOAJ)
- 20 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
124
Most recent article
4 months ago
Average review time (journal-declared via DOAJ)
20weeks
Works in OpenAlex
149
Last recorded publication year
2025
h-index
19
i10-index
44
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2020-05-18
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 95%
- ORCID iDs in current deposits
- 60%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101759453
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Schizophrenia research and treatment
- Tryptophan and brain disorders
- Tryptophan and brain disorders
- Dementia and Cognitive Impairment Research
- Schizophrenia research and treatment
- Schizophrenia research and treatment
- Functional Brain Connectivity Studies
- Functional Brain Connectivity Studies
Show all subjects (75)
- Mental Health and Psychiatry
- Treatment of Major Depression
- Stress Responses and Cortisol
- Stress Responses and Cortisol
- Alzheimer's disease research and treatments
- Neurotransmitter Receptor Influence on Behavior
- Mental Health Research Topics
- Alzheimer's disease research and treatments
- Alzheimer's disease research and treatments
- Mental Health Research Topics
- Tryptophan and brain disorders
- Bipolar Disorder and Treatment
- Bipolar Disorder and Treatment
- Bipolar Disorder and Treatment
- Functional Brain Connectivity Studies
- Dementia and Cognitive Impairment Research
- Dementia and Cognitive Impairment Research
- Neural dynamics and brain function
- Neural dynamics and brain function
- Neural and Behavioral Psychology Studies
- Mental Health Research Topics
- Glaucoma and retinal disorders
- Stress Responses and Cortisol
- Retinal Imaging and Analysis
- Retinal Imaging and Analysis
- Neuroscience and Neuropharmacology Research
- Retinal Imaging and Analysis
- Mental Health and Psychiatry
- Neuroscience and Neuropharmacology Research
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Mental Health and Psychiatry
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Music Perception
- Neurotransmitter Receptor Influence on Behavior
- Cancer-related cognitive impairment studies
- Retinal Diseases and Treatments
- Multiple Sclerosis Research Studies
- Neuroscience and Music Perception
- Parkinson's Disease Mechanisms and Treatments
- Electroconvulsive Therapy Studies
- Glaucoma and retinal disorders
- Treatment of Major Depression
- Neural and Behavioral Psychology Studies
- Treatment of Major Depression
- Neuroscience and Neuropharmacology Research
- Neural and Behavioral Psychology Studies
- Neuroinflammation and Neurodegeneration Mechanisms
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Glaucoma and retinal disorders
- Genetic Associations and Epidemiology
- Receptor Mechanisms and Signaling
- Traumatic Brain Injury Research
- Receptor Mechanisms and Signaling
- Genetic Associations and Epidemiology
- Genetic Associations and Epidemiology
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Neuroinflammation and Neurodegeneration Mechanisms
- Retinal Diseases and Treatments
- Multiple Sclerosis Research Studies
- Autism Spectrum Disorder Research
- Suicide and Self-Harm Studies
- Retinal Diseases and Treatments
- Multiple Sclerosis Research Studies
- Posttraumatic Stress Disorder Research
- Child and Adolescent Psychosocial and Emotional Development
- Child and Adolescent Psychosocial and Emotional Development
- Posttraumatic Stress Disorder Research
Keywords (DOAJ)
- neuropsychiatric disorders
- diagnostic biomarkers
- prognostic biomarkers
- predictive biomarkers
- monitoring biomarkers
- neuroimaging biomarkers
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ